Atara Biotherapeutics Inc (ATRA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

611 GATEWAY BLVD SOUTH SAN FRANCISCO, CA 94080

Atara Biotherapeutics, Inc.(@Atarabio) is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. With its lead program in Phase 3 clinical development, Atara is the most advanced allogeneic T-cell immunotherapy company and intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. Its platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform to create a robust pipeline including: tab-celĀ® in Phase 3 development for Epstein-Barr virus-driven post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-driven diseases; ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR-T) immunotherapies for both solid tumors and hematologic malignancies. Improving patients' lives is its mission and it will never stop working to bring transformative therapies to those in need. Atara is headquartered in South San Francisco and its leading-edge research, development and manufacturing facility is based in Thousand Oaks, California.

Data as of 2021-08-02 08:42:35 -0400
Market Cap1.072 Billion Shares Outstanding84.077 Million Avg 30-day Volume630.33 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.24 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.0321 52-week High/Low28.2 / 11.33 Next Earnings Date2021-08-04 Price to Cash FLow (P/CF) -16.598
Data provided by IEX Cloud
View SEC Filings from ATRA instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 3 -33.33% 1 (0.06%) 2 (0.12%) -50.0%
Funds Holding: 148 148 0.0% 49 (2.88%) 55 (3.19%) -10.91%
13F shares: 85.789 Million 86.624 Million -0.96% 42.267 Million 43.892 Million -3.7%
% Ownership 50.5499 52.8831 -4.41%
New Positions: 22 27 -18.52% 6 16 -62.5%
Increased Positions 61 59 3.39% 22 15 46.67%
Closed Positions 20 19 5.26% 12 9 33.33%
Reduced Positions 42 43 -2.33% 16 18 -11.11%
Total Calls 72.021 Thousand 80.498 Thousand -10.53% 65.4 Thousand 49.205 Thousand 32.91%
Total Puts 23.419 Thousand 87.255 Thousand -73.16% 19.6 Thousand 46.3 Thousand -57.67%
PUT/CALL Ratio 0.33 1.08 -69.44% 0.3 0.94 -68.09%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ATRA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ATRA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

34.4 Thousand total shares from 3 transactions

Open Market Sells (S)

20 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TOUCHON PASCAL PRESIDENT AND CEO

  • Officer
  • Director
345,114 2021-06-25 6

YAREMA KRISTIN CHIEF COMMERCIAL OFFICER

  • Officer
125,882 2021-06-11 3

FUST MATTHEW K

62,354 2021-06-08 1

GALLAGHER CAROL GILTNER

129,318 2021-06-08 1

SEIDENBERG BETH C

1,932,733 2021-06-08 1

DOBMEIER ERIC

56,500 2021-06-08 1

HEIDEN WILLIAM K

49,000 2021-06-08 1

KOPPIKAR UTPAL CHIEF FINANCIAL OFFICER

  • Officer
164,948 2021-06-08 8

BAYNES ROY D.

40,500 2021-06-08 1

RENAUD RONALD C JR

28,500 2021-06-08 1

RONCAROLO MARIA GRAZIA

28,500 2021-06-08 1

NEWELL JOE CHIEF OPERATIONS OFFICER

  • Officer
128,971 2021-05-18 14

MURUGAN AMAR SVP, GC & SECRETARY

  • Officer
91,744 2021-05-18 2

DUPONT JAKOB EVP, HEAD OF R&D

  • Officer
94,945 2021-05-18 2

CIECHANOVER ISAAC E. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
622,930 2019-05-29 0

BERGER DIETMAR GLOBAL HEAD OF R&D

  • Officer
85,678 2019-05-07 0

KIM MINA SENIOR VP & GENERAL COUNSEL

  • Officer
66,389 2019-04-09 0

PORTER DERRELL SVP, HEAD OF GLOBAL COMMERCIAL

  • Officer
31,688 2019-03-26 0

MARCUS JOEL S

  • Director
899,855 2019-03-15 0

HAQQ CHRISTOPHER EVP, R&D & CHIEF SCIENTIFIC OF

  • Officer
291,943 2019-02-15 0

SOFFER GAD EVP & CHIEF STRATEGY OFFICER

  • Officer
243,966 2018-09-22 0

CLARK MITCHALL G. EVP & CHIEF R & QA OFFICER

  • Officer
107,972 2018-05-18 0

MCGRATH JOHN EVP & CHIEF FINANCIAL OFFICER

  • Officer
88,762 2018-03-19 0

TURNER HEATHER D FORMER EVP, GC & SEC.

  • Officer
No longer subject to file 2018-02-09 0

KLEINER PERKINS CAUFIELD & BYERS XV, LLC

KPCB XV ASSOCIATES, LLC

KPCB XV FOUNDERS FUND, LLC

  • 10% Owner
2,176,650 2015-05-19 0

WEBER ECKARD

  • Director
0 2015-01-16 0

DOMAIN PARTNERS VIII, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
2,141,542 2014-10-21 0

DP VIII ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
15,890 2014-10-21 0

DAG VENTURES MANAGEMENT V, LLC

CADEDDU JOHN J.

GOODRICH R. THOMAS

PIANIM NICHOLAS K.

CHUNG YOUNG J.

WILLIAMS GREG

DAG VENTURES V-QP, L.P.

DAG VENTURES V, L.P.

  • 10% Owner
No longer subject to file 2014-10-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

TOUCHON PASCAL - Director - Officer PRESIDENT AND CEO

2021-06-29 16:06:09 -0400 2021-06-25 S 14,194 $16.32 d 345,114 direct yes 3.2154 -6.6881 3.2154 2 -6.6881 6

YAREMA KRISTIN - Officer CHIEF COMMERCIAL OFFICER

2021-06-15 16:02:31 -0400 2021-06-14 P 28,833 $14.58 a 125,882 direct 0.0 0.9115 -15.0391 7.9427 7 -18.0339 29

YAREMA KRISTIN - Officer CHIEF COMMERCIAL OFFICER

2021-06-15 16:02:31 -0400 2021-06-14 P 3,500 $14.48 a 97,049 direct 0.0 0.9115 -15.0391 7.9427 7 -18.0339 29

YAREMA KRISTIN - Officer CHIEF COMMERCIAL OFFICER

2021-06-15 16:02:31 -0400 2021-06-11 P 2,021 $14.50 a 93,549 direct 0.0 0.9115 -15.0391 7.9427 7 -18.0339 29

KOPPIKAR UTPAL - Officer CHIEF FINANCIAL OFFICER

2021-06-09 16:06:44 -0400 2021-06-08 S 5,820 $14.06 d 164,948 direct yes 0.1391 6.815 -11.1961 15.299 11 -11.1961 31

SEIDENBERG BETH C

2021-06-09 19:16:24 -0400 2021-06-08 A 17,500 a 17,500 direct

RENAUD RONALD C JR

2021-06-09 19:13:08 -0400 2021-06-08 A 11,000 a 11,000 direct 0.1391 6.815 -11.1961 15.299 11 -11.1961 31

DOBMEIER ERIC

2021-06-09 19:07:20 -0400 2021-06-08 A 17,500 a 17,500 direct

GALLAGHER CAROL GILTNER

2021-06-09 19:09:11 -0400 2021-06-08 A 11,000 a 111,818 direct 0.1391 6.815 -11.1961 15.299 11 -11.1961 31

BAYNES ROY D.

2021-06-09 19:03:24 -0400 2021-06-08 A 17,500 a 17,500 direct

HEIDEN WILLIAM K

2021-06-09 19:14:44 -0400 2021-06-08 A 17,500 a 17,500 direct

SEIDENBERG BETH C

2021-06-09 19:16:24 -0400 2021-06-08 A 11,000 a 38,189 direct 0.1391 6.815 -11.1961 15.299 11 -11.1961 31

RONCAROLO MARIA GRAZIA

2021-06-09 19:11:20 -0400 2021-06-08 A 17,500 a 17,500 direct

DOBMEIER ERIC

2021-06-09 19:07:20 -0400 2021-06-08 A 11,000 a 39,000 direct 0.1391 6.815 -11.1961 15.299 11 -11.1961 31

FUST MATTHEW K

2021-06-09 19:05:33 -0400 2021-06-08 A 17,500 a 17,500 direct

BAYNES ROY D.

2021-06-09 19:03:24 -0400 2021-06-08 A 11,000 a 23,000 direct 0.1391 6.815 -11.1961 15.299 11 -11.1961 31

HEIDEN WILLIAM K

2021-06-09 19:14:44 -0400 2021-06-08 A 11,000 a 31,500 direct 0.1391 6.815 -11.1961 15.299 11 -11.1961 31

RENAUD RONALD C JR

2021-06-09 19:13:08 -0400 2021-06-08 A 17,500 a 17,500 direct

RONCAROLO MARIA GRAZIA

2021-06-09 19:11:20 -0400 2021-06-08 A 11,000 a 11,000 direct 0.1391 6.815 -11.1961 15.299 11 -11.1961 31

GALLAGHER CAROL GILTNER

2021-06-09 19:09:11 -0400 2021-06-08 A 17,500 a 17,500 direct

FUST MATTHEW K

2021-06-09 19:05:33 -0400 2021-06-08 A 11,000 a 44,854 direct 0.1391 6.815 -11.1961 15.299 11 -11.1961 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 22:15:04 UTC -0.2648 0.3448 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 21:45:03 UTC -0.2648 0.3448 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 21:15:03 UTC -0.2648 0.3448 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 20:45:03 UTC -0.2648 0.3448 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 20:15:04 UTC -0.2648 0.3448 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 19:45:04 UTC -0.2648 0.3448 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 19:15:03 UTC -0.2648 0.3448 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 18:45:03 UTC -0.2648 0.3448 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 18:15:03 UTC -0.2648 0.3448 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 17:45:03 UTC -0.2648 0.3448 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 17:15:03 UTC -0.2648 0.3448 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 16:45:02 UTC -0.2689 0.3489 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 16:15:03 UTC -0.2689 0.3489 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 15:45:03 UTC -0.2689 0.3489 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 15:15:02 UTC -0.2689 0.3489 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 14:45:02 UTC -0.23 0.31 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 14:15:04 UTC -0.23 0.31 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 13:45:04 UTC -0.23 0.31 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 13:15:03 UTC -0.23 0.31 1100000
ATARA BIOTHERAPEUTICS INC ATRA 2021-08-05 12:45:03 UTC -0.23 0.31 1100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
SARATOGA ADVANTAGE TRUST- James Alpha Multi Strategy Alternative Income Portfolio ATRA -787.0 shares, $-13205.86 2021-02-28 N-PORT
James Alpha Funds Trust- James Alpha Multi Strategy Alternative Income Fund ATRA -787.0 shares, $-10671.72 2021-05-31 N-PORT

Elevate your investments